This chemical is primarily utilized in the synthesis of pharmaceuticals, particularly in the development of chiral compounds. It serves as a key intermediate in the production of drugs targeting neurological and cardiovascular disorders. The presence of the tert-butoxycarbonyl (Boc) group protects the amino functionality during synthetic processes, while the cyanophenyl moiety contributes to the compound's biological activity. Its chiral nature makes it valuable in creating enantiomerically pure substances, enhancing the efficacy and reducing side effects of the resulting medications. Additionally, it is employed in research for designing peptide-based therapeutics and enzyme inhibitors.